Medindia
Medindia LOGIN REGISTER
Advertisement

Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium

Tuesday, February 12, 2008 General News
Advertisement
MINNEAPOLIS, Feb. 11 Uroplasty, Inc.(Amex: UPI), a medical device company that develops, manufactures and marketsinnovative proprietary products for the treatment of voiding dysfunction,announced today that the Urgent(R) PC Neuromodulation System, its proprietary,minimally invasive nerve stimulation device, designed for office-basedtreatment of overactive bladder (OAB) symptoms, will be featured in threepresentations at the Society of Urologic Nurses and Associates (SUNA) AnnualSymposium. SUNA will be held at the Marriott Waterside Hotel and Marina inTampa, Florida from Thursday, February 28, through Sunday, March 2. Theseretrospective and observational studies examined the use of Urgent(R) PCNeuromodulation System to deliver the percutaneous tibial nerve stimulation(PTNS) for the treatment of OAB symptoms of urinary urgency, urinaryfrequency, and urge incontinence. The Company will present a summary of thesepresentations on Monday, March 3 before the market opens. The schedule forthe oral presentation and poster-discussion sessions is as follows:
Advertisement

About the Urgent PC Neuromodulation System

The Urgent PC neuromodulation system is a proprietary, minimally invasivenerve stimulation device designed for office-based treatment of OAB symptomsof urge incontinence, urinary urgency and urinary frequency. Application ofneuromodulation therapy targets specific nerve tissue and disrupts the signalsthat lead to the symptoms of OAB. Uroplasty sells the Urgent PC system in theUnited States, Canada and countries recognizing the CE mark. Outside of theUnited States, the Urgent PC is also indicated for the treatment of fecalincontinence.
Advertisement

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-ownedsubsidiaries in The Netherlands and the United Kingdom, is a medical devicecompany that develops, manufactures and markets innovative proprietaryproducts for the treatment of voiding dysfunctions. Our primary focus is thecommercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of overactivebladder (OAB) symptoms. We also offer Macroplastique(R) Implants, a bulkingagent for the treatment of urinary incontinence. Please visit Uroplasty, Inc.at http://www.uroplasty.com.-- Leslie Wooldridge, MSN, RNCS, GNP.F, BCIA-PMBD, Director of the Bladder Control Clinic, Hackley Health at the Lakes Women's Center, Muskegon, Michigan, "Percutaneous Tibial Nerve Stimulation: Revival of an Old Technology for Treatment of Overactive Bladder," Sunday, March 2, at 8 am, oral presentation -- Vanessa K. Hardy, WHNP, APN, MSN, Nurse Practitioner, Urogynecology, Vanderbilt University Medical Center, Nashville, Tennessee, "Percutaneous Tibial Nerve Stimulator: A Viable Option for Urgency, Frequency, and Urge Incontinence," Friday, February 29 through Saturday, March 1, poster presentation -- Lesbia Candelaria, RN, Winter Park Urology Associates, Orlando, Florida, "Percutaneous Tibial Nerve Stimulation (PTNS) Treatment for Overactive Bladder (OAB) Patients in a Community Based Urology Practice," Friday, February 29 through Saturday, March 1, poster presentation

SOURCE Uroplasty, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close